501 related items for PubMed ID: 12629372
1. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J, Rofecoxib Prostatitis Investigator Team.
J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
[Abstract] [Full Text] [Related]
2. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
Nickel JC, Narayan P, McKay J, Doyle C.
J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
[Abstract] [Full Text] [Related]
3. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study.
Nickel JC, Forrest JB, Tomera K, Hernandez-Graulau J, Moon TD, Schaeffer AJ, Krieger JN, Zeitlin SI, Evans RJ, Lama DJ, Neal DE, Sant GR.
J Urol; 2005 Apr; 173(4):1252-5. PubMed ID: 15758763
[Abstract] [Full Text] [Related]
4. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN.
J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
[Abstract] [Full Text] [Related]
5. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI.
BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
[Abstract] [Full Text] [Related]
6. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
Katz N, Ju WD, Krupa DA, Sperling RS, Bozalis Rodgers D, Gertz BJ, Gimbel J, Coleman S, Fisher C, Nabizadeh S, Borenstein D, Vioxx Chronic Low Back Pain Study Group.
Spine (Phila Pa 1976); 2003 May 01; 28(9):851-8; discussion 859. PubMed ID: 12941996
[Abstract] [Full Text] [Related]
7. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Brähler E, Weidner W.
Eur Urol; 2009 Sep 01; 56(3):544-51. PubMed ID: 19524353
[Abstract] [Full Text] [Related]
8. Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies.
Daniels SE, Desjardins PJ, Bird SR, Smugar SS, Tershakovec AM.
Clin Ther; 2006 Jul 01; 28(7):1022-34. PubMed ID: 16990080
[Abstract] [Full Text] [Related]
9. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
Bates SM, Hill VA, Anderson JB, Chapple CR, Spence R, Ryan C, Talbot MD.
BJU Int; 2007 Feb 01; 99(2):355-9. PubMed ID: 17313424
[Abstract] [Full Text] [Related]
10. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
Michael Hill C, Sindet-Pederson S, Seymour RA, Hawkesford JE, Coulthard P, Lamey PJ, Gerry Cowan C, Wickens M, Jeppsson L, Dean AD, Svensson O.
Clin Ther; 2006 Sep 01; 28(9):1279-95. PubMed ID: 17062301
[Abstract] [Full Text] [Related]
11. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial.
Nickel JC, Downey J, Johnston B, Clark J, Canadian Prostatitis Research Group.
J Urol; 2001 May 01; 165(5):1539-44. PubMed ID: 11342913
[Abstract] [Full Text] [Related]
12. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
Morgia G, Mucciardi G, Galì A, Madonia M, Marchese F, Di Benedetto A, Romano G, Bonvissuto G, Castelli T, Macchione L, Magno C.
Urol Int; 2010 May 01; 84(4):400-6. PubMed ID: 20332612
[Abstract] [Full Text] [Related]
13. The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain.
Chelly JE, Nissen CW, Rodgers AJ, Smugar SS, Tershakovec AM.
Curr Med Res Opin; 2007 Jan 01; 23(1):195-206. PubMed ID: 17207303
[Abstract] [Full Text] [Related]
14. Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial.
Lee SH, Lee BC.
Urology; 2009 May 01; 73(5):1036-41. PubMed ID: 19394499
[Abstract] [Full Text] [Related]
15. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome.
Nickel JC, Downey J, Ardern D, Clark J, Nickel K.
J Urol; 2004 Aug 01; 172(2):551-4. PubMed ID: 15247727
[Abstract] [Full Text] [Related]
16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
[Abstract] [Full Text] [Related]
17. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
Shoskes DA, Nickel JC, Kattan MW.
Urology; 2010 Jun 01; 75(6):1249-53. PubMed ID: 20363491
[Abstract] [Full Text] [Related]
18. [Effects of Huafenqinutang and vardenafil for treatment of chronic prostatitis/chronic pelvic pain syndrome with concomitant erectile dysfunction].
Lin ZF, Chen BT, Zeng K, Lan HM, Wun J.
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr 01; 27(4):532-4. PubMed ID: 17545052
[Abstract] [Full Text] [Related]
19. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.
Birbara C, Ruoff G, Sheldon E, Valenzuela C, Rodgers A, Petruschke RA, Chang DJ, Tershakovec AM.
Curr Med Res Opin; 2006 Jan 01; 22(1):199-210. PubMed ID: 16393445
[Abstract] [Full Text] [Related]
20. Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study.
Nickel JC, O'Leary MP, Lepor H, Caramelli KE, Thomas H, Hill LA, Hoel GE.
J Urol; 2011 Jul 01; 186(1):125-31. PubMed ID: 21571345
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
